992
J Biol Inorg Chem (2015) 20:989–1004
H3′), 6.48 (m, 1H, H1′), 6.96 (bs, 1H, Im-CH-5), 7.79 (bs,
1H, Im-CH-2), 8.44 (s, 1H, H2), 8.53 (s, 1H, H8), 9.01 (bs,
1H, CONH).
conditions the same as described for the compound 1); UV
(H2O): λmax = 209.0 nm, ε = 20 941 dm3 mol−1 cm−1
,
λmax = 269.4 nm, ε = 18 274 dm3 mol−1 cm−1; (HRMS,
FAB): m/z = 432.1661, [M + H]+, calculated for
C17H22N9O5 requires 432.1666; 1H NMR (250 MHz,
D2O, DMSO) δ 2.40 (ddd, 1H, JH2′,H3′ = 3.6 Hz,
JH2′,H1′ = 6.8 Hz, Jgem = 13.3 Hz, H2′), 2.71 (m, 1H, H2″),
3.05 (m, 2H, CH2-β), 3.57 (dd, 1H, JH5′,H4′ = 4.3 Hz,
Jgem = 12.2 Hz, H5′), 3.66 (dd, 1H, JH5″,H4′ = 3.7 Hz,
Jgem = 12.2 Hz, 5″), 3.96 (m, 1H, H4′), 4.25–4.51 (signals
superimposed with the signal of water molecule: CH-α,
H3′), 6.33 (pt, 1H, JH1′,H2′ = JH1′,H2″ = 6.8 Hz, H1′), 6.99
(s, 1H, Im-CH-5), 7.61 (s, 1H, Im-CH-2), 8.50 (s, 1H, H2),
8.51 (s, 1H, H8).
Synthesis of methyl ester of N2‑{[9‑(2′‑d‑deoxyribofuranos
yl)‑9Hpurin‑6‑yl]‑carbamoyl}‑l‑histidine (his6dA ester) (1)
Methyl
ester
of
N2-{[9-(3′,5′-di-O-acetyl-d-2′-
deoxyribofuranosyl)-9Hpurin-6-yl]-carbamoyl}-l-histidine
f (140 mg, 0.26 mmol) was dissolved in 3 mL of trieth-
ylamine solution in methanol (1:9 v/v). After 3 days,
TLC control indicated complete reaction of the substrate
(CHCl3/MeOH 80:20 v/v). The solvent was evaporated
under reduced pressure and the residual solid was coevap-
orated with toluene. The obtained product was then puri-
fied by column chromatography on silica gel eluting with a
gradient: 0 % MeOH in CHCl3 to 60 % MeOH in CHCl3.
Traces of triethylamine left in the product were removed
by coevaporation several times with methanol and tolu-
ene. The desired compound 1 was obtained as white foam
(82 mg, 0.18 mmol, 68 % yield), TLC: Rf = 0.18, (CHCl3/
MeOH 80:20 v/v), HPLC: Rf = 21.95 min (XTerra®
HPLC column MS C8, 5 μm 4,6 × 150 mm, flow 1 mL/
min, 20 °C, detection at λ = 254 nm; gradient elution—
solvent A—5 mM TEAB o pH = 7.5, solvent B = AcCN;
0–25 min from 0 to 30 % of B, 25–30 min 50 % of B);
Potentiometric measurements
The deprotonation constants of the ligands (pKa) and the
stability constants of Cu(II) complexes (log β) were deter-
mined by pH-potentiometric titrations of 2.0 mL samples.
The ligand:metal molar ratio was in the range 2:1, and the
concentration of Cu(II) was 1 × 10−3 M.
Measurements was carried out at 298 K and at the con-
stant ionic strength of 0.1 M KNO3 with a MOLSPIN
pH meter (Molspin Ltd., Newcastle-upon-Tyne, UK),
equipped with a digitally operated syringe (the Molspin
DSI 0.250 mL) controlled by computer. The titrations
were performed with a carbonate-free NaOH solution of
known concentration (ca. 0.1 M) using a Russel CMAWL/
S7 semi-micro combination pH electrode, calibrated for
hydrogen ion concentration by the method of Irving et al.
[7]. The number of experimental points was 100–150 for
each titration curve. The reproducibility of the titration
points included in the evaluation was within 0.005 pH units
in the whole pH range examined (2–11.5). Protonation con-
stants of the ligand and the overall stability constants of the
complexes were calculated by SUPERQUAD program [8],
which minimizes the sum of the weighted squared residuals
between the observed and the calculated e.m.f. values. Dis-
tribution diagrams for the various systems were calculated
and plotted by the program HYSS [9].
UV (H2O): λmax = 209.4 nm, ε = 25,942 dm3 mol−1 cm−1
,
λmax = 269.2 nm, ε = 22 140 dm3 mol−1 cm−1; (HRMS,
FAB): m/z = 447.1657, [M + H]+, calculated for
C18H23N8O6 requires 447.1662; 1H NMR (250 MHz,
D2O) δ 2.43 (ddd, 1H, JH3′,H2′ = 3.4 Hz, JH2′,H1′ = 6.8 Hz,
Jgem = 14.2 Hz, H2′), 2.69 (m, 1H, H2″), 3.17 (m, 2H,
CH2-β), 3.67 (m, 5H, CH3, H5′, H5″), 4.04 (m. 1H, H4′),
4.52 (m, 1H, CH-α), 4.58–4.70 (signal superimposed
with the signal of water molecule: H3′), 6.48 (pt, 1H,
JH1′,H2′ = JH1′,H2″ = 6.8 Hz, H1′), 7.02 (s, 1H, Im-CH-5),
7.88 (s, 1H, Im-CH-2),8.27 (s, 1H, H8), 8.28 (s, 1H, H2).
Synthesis of amide of N2‑{[9‑(2′‑d‑deoxyribofuranosyl)‑9H
purin‑6‑yl]‑carbamoyl}‑l‑histidine (his6dA amide) (2)
Methyl
ester
of
N2-{[9-(3′,5′-di-O-acetyl-d-2′-
deoxyribofuranosyl)-9Hpurin-6-yl]-carbamoyl}-l-histidine
f (70 mg, 0.11 mmol) dissolved in 6 mL of methanol
saturated with gaseous ammonia. After 2 days of stirring
at room temperature TLC control (nBuOH/H2O 85:15
v/v) indicated complete disappearance of the substrate.
The solvent was evaporated under reduced pressure. The
obtained product was purified using column chromatogra-
phy on silica gel eluting with nBuOH/H2O system (85:15
v/v). Compound 2 was obtained as white foam (17 mg,
0.04 mmol, 40 % yield), TLC: Rf = 0.4, (nBuOH/H2O
85:15 v/v),); HPLC: Rf = 15.90 min (HPLC column and
Spectroscopic measurement
UV–visible (UV–Vis) spectra were recorded with a Perkin-
Elmer Lambda 11 spectrophotometer, in the same con-
centration range as used for the potentiometry. Circular
dichroism (CD) spectra were obtained with a Jobin–Yvon
CD-6 dichrograph in the ultraviolet (UV) and visible range,
using 0.05 cm and 1 cm cuvettes, respectively. The spectra
are expressed as Δε = εl − εr, where εl and εr are molar
absorption coefficients for left and right circularly polar-
ized light, respectively. Anisotropic X-band EPR spectra
1 3